![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Dragon Pharmaceutical Reports US$943,000 Loss for 2004
Dragon Pharmaceutical Reports US$943,000 Loss for 2004
March 31, 2005
Dragon Pharmaceutical Inc. cut its annual loss for 2004 in half compared with 2003, helped by a recovery of $2.1 million that had earlier been written-off. The generic drug company with operations in China said Wednesday it lost $943,000 or five cents per share in 2004. That compared with a loss of $2 million or 10 cents per share in 2003. Revenue for the year increased to $3.7 million, up slightly from $3.6 million the previous year.
Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=072e03e363d82ba1&cat=6dcd932030878143)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct